Back My cancer has not gone away or has come back Cancer progressed on treatment Answer each question to find trials that best match your clinical situation. You can leave questions blank if you do not know the answer. This search will output a list of trials for which you may be eligible based on the criteria you enter. I want to enter information about my cancer and treatments I want to enter information about my genetic testing (e.g, BRCA) and/or tumor testing results I want to filter the trials based on location, phase of development, tumor genomic alteration, or drug name, category or target Phase: selectPhase 1Phase 1 with expansionPhase 1 with ovarian expansionPhase 2Phase 3 Drug Category: selectAngiogenesis InhibitorsAntibody Drug ConjugatesApoptosis InducersB-cell antigen receptor (BCR) Signaling Pathway InhibitorsCell Cycle InhibitorsChemotherapyChromatin Structure/Gene Expression RegulatorsDNA Damage Repair Pathway Inhibitors: ATM, ATR, DNA-PK, etcDNA Damage Repair Pathway Inhibitors: PARPGene TherapyGrowth Factor InhibitorsGrowth Factor Receptor InhibitorsHormonal TherapyImmunotherapy: Anti-Tumor AntibodiesImmunotherapy: BispecificsImmunotherapy: Cellular TherapyImmunotherapy: Checkpoint InhibitorsImmunotherapy: Immune Cell StimulatorsImmunotherapy: ImmunomodulatorsImmunotherapy: VaccinesOncolytic VirusesRadiotherapy: RadiationRadiotherapy: RadioimmunoconjugatesSignaling Pathway Inhibitors: HedgehogSignaling Pathway Inhibitors: Integrins-FAKSignaling Pathway Inhibitors: JAK-STATSignaling Pathway Inhibitors: NotchSignaling Pathway Inhibitors: PI3K-AKT-mTORSignaling Pathway Inhibitors: RAS-RAF-MEK-ERKSignaling Pathway Inhibitors: TGF-betaSignaling Pathway Inhibitors: WNT/Beta-catenin Drug Name: TTfields No preference[225Ac]-FPI-1434177Lu-FAP-22862141 V-1123ME-00610ABBV-151ABBV-367ABBV-CLS-484ABBV-CLS-579AbemaciclibAbexinostatABL503ABM-1310ABSK021ACE1702AdagrasibAdavosertibADCT-901ADG106ADG116ADP-A2M4CD8AfatinibAFM24AfuresertibAG-270AGEN2373agenT-797AGI-134AldesleukinAlectinibAlpelisibAlpha-DC1 vaccineALPN-202AlrizomadlinALRN-6924AMG 193AMG 256AMG 650AMXI-5001AMXT 1501AN4005AnastrozoleAnlotinibanti-EGFR AbAO-176APG-1387APL-2ART0380ART4215ARX788ASN004ASP0739ASP1570ASP7517ASP9801ASTX029ASTX727AtezolizumabATRC-101ATRN-119Autologous nCTLsAutologous TILsAvapritinibAvelumabAxitinibAza-TdCAZD5305AZD7648AZD8205AZD8701BalstilimabBatiraxceptBAY2416964BAY2666605BAY2701439BB-1701BBP-398BCA101BDB018BDC-1001BDTX-189BelinostatBempegaldesleukinBerzosertibBevacizumabBexmarilimabBGB-15025BGB-3245BGB-A425BI 1387446BI 754111BI 765179BI 907828BI-1206BinimetinibBintrafusp alfaBIO-106BirinapantBJ-001BJ-005BLU-222BMS-986156BMS-986207BMS-986218BMS-986288BMS-986299BMS-986406BNT141BNT142BNT151BNT152BNT153BortezomibBosutinibBotensilimabBozitinibBPX-603BT4780BT5528BT8009BTX-1188BTX-A51BudigalimabBuparlisibBusulfanCAB-CTLA-4CabozantinibCAL056 mesylateCamidanlumab tesirineCamonsertibCAN1012CapecitabineCapivasertibCAR.B7-H3CarboplatinCART-TnMUC1CBX-12CCS1477CDKiCDX-1140CDX-527CediranibCemiplimabCeralasertibCetuximabCFI-402257CFI-402411CFT8634CI-8993CiforadenantCirtuvivintCisplatinCLN-619ClofarabineClostridium Novyi-NTCM24CMP-001CobimetinibColchicineCOM701COM902CopanlisibCotsiranibCPI-006CPI-0209CPI-100CPO-100CrizotinibCRX-100CS5001CT-0508CTX-471CYC140CyclophosphamideCYH33CYT-0851D-1553DabrafenibDasatinibDAY101DB-1303DCC-3116Debio 0123DefactinibDenileukin diftitoxDeTIL-0255DF1001DF6002DFP-14927DinaciclibDocetaxelDostarlimabDoxorubicinDS-6000aDSP-0509DSP107DurvalumabDZ-002E-602E7046E7766EbvaciclibEfineptakin alfaEflornithineELI-002ElimusertibELU001EMB-02ENB003EncorafenibEnfortumab VedotinEntinostatEntrectinibEnzalutamideEOS-448EP0057ERAS-007ERAS-601ErdafitinibEribulinErlotinibES002023EtigilimabEtoposideEU101EverolimusEzabenlimabFadraciclibFF-10850 Topotecan LiposomeFloxuridineFludarabineFostamatinibFS120FSHCER T cellsFT500FT538FulvestrantFutibatinibGamitrinibGavocabtagene autoleucelGDC-1971GDC-6036GedatolisibGemcitabineGEN-001GEN-1GiredestrantGNX102GRN-300GS-1811GS-3583GS-9716GSK3745417GSK4381562GSK6097608GunagratinibHB0025HCW9218HH2710HH2853HIPECHL-085HM30181AHMBD-002HPN536hSTC810huCART-meso cellsHuMax-IL8HydroxychloroquineIACS-6274IBI322ICT01IdasanutlinIDE397IGM-8444IK-930IL-12IL-15IMA203IMC-002IMC-C103CIMC-F106CIMP7068IMP9064IMSA101InavolisibINBRX-105INCAGN01949INCB099280INCB106385INCB123667Individual Patient TCR-Transduced PBLInfigratinibInupadenantINV-1120IO-108ION537IpatasertibIPG7236IpilimumabIrinotecanIvosidenibJAB-21822JAB-3312JAB-8263JAB-BX102JBI-802JDQ433JSI-1187JTX-8064KB-0742KD033KIN-2787KIN-3248KSQ-4279KT-333KZR-261LapatinibLarotrectinibLemzoparlimabLenvatinibLetrozoleLifirafenibLiposomal doxorubicinLiposomal irinotecanLisaftoclaxLM-108LN-145-S1LNS8801LorigerlimabLorlatinibLVGN3616LVGN6051LVGN7409LY3295668LY3410738LY3537982LYT-200M1231M1774M4344M6223M-CENKMCLA-145MDNA11MEDI1191MEDI5752MEDI9253MEKiMetarrestinMetforminMethoxyamineMGC018MilademetanMinnelideMinoxidilMirdametinibMirvetuximab soravtansineMitomycin CMK-0482MK-2118MK-4830MK-5890MORAb-202MOv19-BBz CAR TMPT-0118MRG002MRG004AMRTX1719MT-5111MT-6402MTB-9655mTORiMVF-HER-2(597-626)-MVF-HER-2 (266-296) peptide vaccineMV-NISMV-NIS infected mesynchymal stem cellsnab-Paclitaxelnab-SirolimusNavicixizumabNavitoclaxNBE-002NBTXR3NC762NDI-101150NedisertibNelfinavir mesylateNemvaleukin alfaNeoantigen specific TCR-T cell drug product (Sleeping Beauty)NeoVaxNeratinibNG-350ANG-641NGM438NGM707NGM831NHS-IL12NilotinibNiraparibNivolumabNIZ985NL-201NM21-1480NMS-03305293Nogapendekin alfaNP-G2-044NT219NUV-868NVL-520NY-ESO-1 TCR transgenic T cells and NY-ESO-1 TCR/sr39TK transgenic stem cellsNZV930OBI-3424OBI-999OBT076OKI-179OlaparibOlvimulogene nanivacirepvecON 123300Onapristone ERONC201ONC-392ONCR-177OR2805OregovomabORIN1001Oxaliplatinp53MVAPaclitaxelPaclitaxel-loaded TPMPalbociclibPamiparibPARPiPaxalisibPazopanibPBI-200PC14586PD-1iPD-L1iPembrolizumabPemetrexedPEN-866PertuzumabPF-06940434PF-07104091PF-07209960PF-07220060PF-07257876PF-07260437PF-07263689PF-07265807PF-07284892PHESGOPidnarulexPimasertibPimivalimabPIPACPLX8394P-MUC1C-ALLO1 CAR-T cellsPoziotinibPralsetinibPrexigebersen-APRGN-3005 Ultra CAR T cellsProAgioPRT2527PRT811PT01PTX-35PUR001PY159PY314Q702Radiation TherapyRBN-2397RBS2418REGN4018REGN5668REGN7075RegorafanibRelacorilantRelatlimabRepotrectinibRetifanlimabRibociclibRiMO-301RintatolimodRIVAL-01RLY-2608RLY-4008RMC-4630RMC-5552RO7296682RO7444973RP1RP-6306RSC-1255RTX-240RucaparibRunimotamabRX108S095029Sacituzumab govitecanSAR441000SAR443216SasanlimabSB 11285SEA-TGTSelected Young TILSelinexorSelpercatinibSelumetinibSenaparibSerabelisibSeribantumabSGN-ALPVSGN-B6ASGN-B7H4VSGN-STNVSHetA2SHP2iSirolimusSirpiglenastatSL-172154SL-279252Sleeping Beauty Transposed PBLSNK01SNX281SON-1010SOR-C13SOT101SotorasibSpartalizumabSQ3370SRF388SRK-181ST-067STI-3258STI-6643STK-012STP707STRO-002SunitinibSurgerySurufatinibSym021SYNB1891T3011TAA-CTLTAB004TAC01-HER2TAEK-VAC-HerByTAG72-CAR T cellsTalabostatTaladegibTalazoparibTalimogene laherparepvecTaminadenantTAS0953/HM06TAS-117TazemetostatTBX-3400TCR-TTemozolomideTemsirolimusTemuterkibTG4050TH1902ThermotherapyTHOR-707TinostamustineTiragolumabTislelizumabTivozanibTJ210TJ-CD4BTNG908TNO155TopotecanToripalimabTORL-1-23TORL-2-307-ADCTORL-2-37-MABTP-1287TPX-0022TPX-4589TrametinibTransCon IL-2 β/γTransCon TLR7/8TrastuzumabTrastuzumab deruxtecanTrastuzumab emtansineTRE-515TremelimumabTRK-950TST001TST005TT-00420TTfieldsTTI-101TTI-622TTX-030TU2218TucatinibUCT-01-097UCT-03-008UliledlimabUlixertinibUpifitamab rilsodotinV937V938Valproic acidVandetanibVB10.NEOVCN-01VeliparibVemurafenibVinorelbineVIP152VismodegibVMD-928VS-6766VT3989VudalimabWNT974XB002XL092XL102XmAb22841XmAb24306XRD-0394XTX101XTX202ZafirlukastZB131ZeaxanthinZEN-3694ZenocutuzumabZilovertamab vedotinZL-1201ZN-c3ZW49ZX-4081 Location: selectAlabamaAlaskaArizonaArkansasCaliforniaColoradoConnecticutDelawareDistrict of ColumbiaFloridaGeorgiaHawaiiIdahoIllinoisIndianaIowaKansasKentuckyLouisianaMaineMarylandMassachusettsMichiganMinnesotaMississippiMissouriMontanaNebraskaNevadaNew HampshireNew JerseyNew MexicoNew YorkNorth CarolinaNorth DakotaOhioOklahomaOregonPennsylvaniaRhode IslandSouth CarolinaSouth DakotaTennesseeTexasUtahVermontVirginiaWashingtonWest VirginiaWisconsinWyoming Molecular Target: No preference No preference4-1BB (CD137)5T4 oncofetal AgA2a/bRA2aRA2RAblACSS2 (Acetyl-CoA Synthetase 2)AHR (aryl hydrocarbon receptor)AktAKT1-3ALKAlpha v beta 3Alpha v beta3,5,6Alpha-2-3-N-linked sialic acidsAlpha-2-6-N-linked sialic acidsAlpha-V/Beta-8 integrinALPP (Alkaline phosphatase, placental)AMPKARArginineARK5AromataseATMATRAURKAURKAAURKBAxlB7H3B7H4BclBcl-2Bcl-wBcl-XLbcr-ablBETBRAFBranched Lewis B/Lewis Y antigenBRD4BRD9BTLA (CD272)BTN1A1BTN3A (CD277)C3C5aRCA125CBPCCR1CCR5CCR8CD163CD200R1CD205CD25CD27CD28CD3CD32BCD39CD40CD46CD47CD73CD96CDH6CDKCDK1/2CDK2CDK2/4/6CDK2/5/9CDK4CDK4/6CDK5CDK7CDK9CEACAM1 (CD66a)CK1alphac-KitCLDN18.2 (Claudin 18.2)CLDN6 (Claudin 6)Clever-1/Stabilin-1CLKCLK1CLK2CLK3CLK4c-MetCOX-2CRM1CSF1R (fms)CSP (Cancer Specific Plectin)CTLA-4CXCRCXCR3CYSLTR1 (cysteinyl leukotriene 1 receptor)DAFdCK (deoxycytidine kinase)DCKzeta (diacylglycerol kinase zeta)DHFR (Dihydrofolate reductase)Dipeptidyl peptidaseDLL4DNADNA polymerase alphaDNA-PKDNMT (DNA methyltransferase)Dyrk1aEF-2 (Elongation Factor 2)EGFREGFR (kinase)Endothelin BR (ETBR)ENPP1EP4 (prostaglandin E2 receptor subtype 4)EphA2ERERBB3(HER3)ERKERK1ERK1/2ERK2EZH1EZH1/2EZH2FAKFAP (fibroblast activation protein alpha)FascinFcγRIII (CD16)FcγRIIIa (CD16A)FGFRFGFR1FGFR1,3FGFR1-4FGFR2FGFR2,3FGFR3FKBP-12FLT3FLT3RFOXP3FRalpha (Folate receptor 1)FSHR (Follicle Stimulating Hormone Receptor)Galectin-9GARPGAS6GITR Globo H (globohexaosylceramide)GlutaminaseGlycolipidsGlycoproteinsGM-CSFRGPER (G protein-coupled estrogen receptor)GRGrb2Grp78GSPT1HDAC (Histone deacetylase)HDAC6 (histone deacetylase 6)HER2HER2 (kinase)HER4HIV proteaseHPK1 (hematopoietic progenitor kinase I)Hsc70Hsp70Hsp90IAPICAM-1IDH1IFNR alphaIGF-1RIKZFIKZF1IKZF3IL-12RIL-15RIL-18RIL-2/IL-15R beta/gammaIL-21RIL-27IL-2RIL-2R alphaIL-2R betaIL-7RIL-8ILT2ILT3ILT4Integrin beta-6IRE1alphaIRS1/2ItkJAKKAAG1KIF18AKir6/SUR2 channelKRASLAG-3 (lymphocyte activation gene-3)LAIR-1 (CD305)latent TGFbeta1LckLSD1LysosomeMAGE-A4MALT-1MAT2A (methionine adenosyltransferase 2A)MCL1MDMMDM2MDMXMEKMEK1MEK1/2MerMesothelinMICAMICA/B (MHC class I chain-related protein A and B)MICBMitochondrial Hsp70Mitochondrial Hsp90MPS1 (TTK)mTORMUC1MUC16 (CA125)MUC1-CNaPi2bNectin-4NeoantigensNF-kappaBNKG2ANLRP3NOS (Nitric oxide synthase)NRASNTRK (Trk)NTRK1 (TrkA)NTRK1-3 (TrkA-C)NTRK2 (TrkB)NTRK3 (TrkC)NY-ESO-1ODC (ornithine decarboxylase)OX40p300p53_ap53_gpan-CDKpan-PI3KPARPPARP1PARP1/2PARP1-3PARP7PD-1PDE3APDGFRPDGFRaPDGFRbPD-L1PGPPI3KPI3K alphaPI3K betaPI3K gammaPI3K/mTORPKMYT1PLK-1Pol I (RNA polymerase I)PolQ (theta)Polyamine TransportPORCNPRPRAMEPRMT5proteasome-20SPTEF- bPTEF-b/CDK9PTPN2PVRIGRAD51RAFRASRETRibonucleoprotein (RNP) complexRibosomeROR1ROSROS1RRM1(Ribonucleotide reductase)Sec61Serotonin (5-HT) 1B/1D receptorSHP2Sialyl Thomsen-nouveau (STn)SIKSIK2SIK3SLFN12SmoothenedSodium Potassium PumpSORT1SRCSRC family kinasesSTAT3STINGSykTACTILETAG72 (tumor-associated glycoprotein 72)TEADTGFbetaTGFbeta1TGFbetaR1TIE-2TIGITTIM-3Tissue FactorTLRTLR3TLR7TLR7/8TLR8TLR9TNFRSF25 (DR3)TnMUC1TOPO ITOPO II (TOP2A)TORCTORC1TRAILR2 (DR5)TREM1TREM2TROP2 [EGP-1 (epithelial glycoprotein-1)]TRPV6 calcium channelTS (Thymidylate synthase)TubulinTumor Associated AntigensULKULK1ULK1/2ULK2UndisclosedUSP1 (ubiquitin-specific protease inhibitor 1)VEGFVEGFRVEGFR1,2,3VEGFR2VEGFR2/3VEGFR3VISTAWEE1WT1WT1, PRAME, and survivinYAP1 (yes-associated protein 1) Other Common Drug Names: No preference No preference14-Hydroxydaunomycin2-difluoromethylornithine hydrochloride2-F-ara-AMP5-aza-4'-Thio-2'-Deoxycytidine5-FUDRA genetically modified oncolytic viral strain of the herpes simplex type 1 (HSV-1) virusA humanized anti-B7-H3 antibody conjugated to the vc- seco - DUocarmycin-hydroxyBenzamide-Azaindole (DUBA) 2 DNA alkylating payloadA2A receptor antagonist EOS100850A-855071.0ABBV-181ABI-007ABI-009Abiplatin ABL111AbraxaneABT-263ABT-888AccolateACT50ADC ARX788ADC DS-8201aADCT-301adenosine A2A receptor antagonist NIR178adenosine-A2A receptor antagonist CPI-444ado trastuzumab emtansineAF802Afatinib dimaleateAfinitorAG-013736AG-014699AG-120AGEN1181AGEN2034agonistic anti-OX40 monoclonal antibody INCAGN01949AK-01AKR1C3-activated prodrug OBI-3424Akt inhibitor AZD5363Akt Inhibitor GDC-0068AKT/ERK inhibitor ONC201AL3818aldesleukin prodrug NKTR-214AlecensaAlimtaALK inhibitor CH5424802ALK/ROS1/NTRK/SRC multi-kinase inhibitor TPX-0005ALKS4230ALT-803AmetycineAMG 510AMN 107AMX513 dicaprateAN0025AN2025anaplastic lymphoma kinase inhibitor CH5424802ANB011Anti programmed death ligand 1 monoclonal antibodyanti-AXL fusion protein AVB-S6-500Anti-B7H1 Monoclonal Antibody MEDI4736anti-C5aR1 monoclonal antibody TJ210anti-CD137 agonistic monoclonal antibody ADG106anti-CD137 agonistic monoclonal antibody LVGN6051anti-CD205 antibody-drug conjugate OBT076anti-CD25 monoclonal antibody RO7296682anti-CD25-PBD antibody-drug conjugate ADCT-301anti-CD32B monoclonal antibody BI-1206anti-CD39 monoclonal antibodyanti-CD47 monoclonal antibody ZL-1201anti-CD73 monoclonal antibody CPI-006anti-CD96 monoclonal antibody GSK6097608anti-claudin 18.2 antibody-drug conjugate LM-302anti-Clever-1 mAbanti-CTLA4 human monoclonal antibody CP-675,206anti-CTLA-4 monoclonal antibody AGEN1181anti-CTLA4 monoclonal antibody BMS-986218anti-CTLA-4 probody BMS-986288anti-CTLA-4/LAG-3 bispecific antibody XmAb22841Anti-Cytotoxic T-Lymphocyte-Associated Antigen-4 Monoclonal Antibodyanti-DLL4/VEGF bispecific monoclonal antibody OMP-305B83Anti-EGFR Monoclonal AntibodyAnti-erbB2 Monoclonal AntibodyAnti-FOLR1-mab Maytansinoid Conjugateanti-GARP monoclonal antibody ABBV-151anti-globo H/MMAE antibody-drug conjugate OBI 999anti-HER2 ADC DS-8201aanti-HER2 antibody-drug conjugate ARX788anti-HER2 antibody-drug conjugate DS-8201aanti-HER2 CAR macrophagesanti-HER2 oNK cellsanti-HER2 x anti-CD3 bispecific monoclonal antibody BTRC 4017Aanti-HER2/Anti-HER3 bispecific monoclonal antibody MCLA-128anti-hFcγRIIB monoclonal antibody BI-1206anti-IL-27p28 monoclonal antibody SRF388anti-IL-8 monoclonal antibody HuMax-IL8anti-ILT2/anti-ILT4 monoclonal antibody NGM707anti-ILT4 monoclonal antibody MK-4830Anti-LAG-3 monoclonal antibody BMS-986016anti-latent TGF-beta 1 monoclonal antibody SRK-181anti-MUC16/CD3 bispecific antibody REGN4018anti-PD-1 antibody-interleukin-21 mutein fusion protein AMG 256anti-PD-1 checkpoint inhibitor PF-06801591Anti-PD-1 human mab MDX-1106anti-PD1 monoclonal antibody ABBV-181anti-PD1 monoclonal antibody AGEN2034anti-PD-1 monoclonal antibody BGB-A317anti-PD-1 monoclonal antibody BI 754091anti-PD-1 monoclonal antibody JTX-4014anti-PD-1 monoclonal antibody MGA012anti-PD-1 monoclonal antibody PDR001anti-PD-1 monoclonal antibody REGN2810anti-PD-1 monoclonal antibody TSR-042anti-PD-1 x IL-21 muteinanti-PD-1/anti-CTLA-4 DART protein MGD019anti-PD-1/CTLA-4 bispecific antibody MEDI5752anti-PD1/CTLA4 bispecific antibody XmAb20717Anti-PD-L1Anti-PD-L1 Monoclonal Antibody MPDL3280A anti-PD-L1/4-1BB bispecific antibody INBRX-105anti-PD-L1/anti-4-1BB bispecific antibody ABL503anti-TIGIT monoclonal antibody BMS-986207anti-TIGIT monoclonal antibody SGN-TGTanti-TIGIT OMP-313M32anti-TROP-2 Antibody-Drug Conjugate IMMU-132anti-VEGF monoclonal antibodyAnzataxAPG-115APG-2575APL-101ARC fusion protein SL-279252ARGX-115ArimidexARRY-067ARRY-142886ARRY-162ARRY-438162ARRY-558aryl hydrocarbon receptor antagonist BAY2416964AS703026ASN007AsotaxATR kinase inhibitor AZD6738ATR kinase inhibitor BAY1895344ATR kinase inhibitor M1774ATR kinase inhibitor VX-970AtvogenAUR102Aurora kinase A/B inhibitor TT-00420autologous aDC1-induced CTLsautologous anti-mesothelin T-cell receptor fusion construct T cells TC-210autologous anti-MUC16 CAR-mbIL15-HER1t T cells PRGN-3005autologous cytokine-induced killer cells/vaccinia virus DD-CDSR CRX100autologous genetically-modified MAGE-A4 C1032 CD8alpha T cellsautologous HER2-targeted dual-switch CAR T cells BPX-603autologous memory cytokine-enriched natural killer cellsAutologous Natural Killer Cell-like nCTLsautologous natural killer-like cytotoxic lymphocytesAutologous NK cellsautologous PBLs retrovirally-transduced with TCRs targeting neoantigensautologous TBX-4000-treated peripheral blood mononuclear cells TBX-3400autologous TCR-engineered T cells IMA203Autologous Tumor Infiltrating Lymphocytes LN-145-S1AV-951AvastinAVB-500AVB-S6-500AZD1775AZD2171AZD2281AZD5363AZD6244AZD6474AZD6738B1939 mesylateB43.13BA3071BavencioBAY 80-6946BAY1251152BAY1895344BAY73-4506Bcl-2 Family Protein Inhibitor ABT-263Bcl-2 inhibitor APG 2575BemaciclibBeneflurBET bromodomain inhibitor ZEN-3694BGB-283BGB-A317BGJ398BI 754091BIBW 2992 MA2BiovelbinBi-SialidaseBKM120Blastolem BLU-667BMN-673BMS-354825BMS-907351BMS-936558BMS986016BMS-986253BNT131BNT142 RiboMab (mRNA-encoded antibody)BosulifBP1001-ABRAF inhibitor GSK2118436BRAF inhibitor PLX8394BRAF/EGFR inhibitor BGB-283Briplatin BristaxolBT5528 - an EphA2-targeting Bicycle Toxin ConjugateBT5528-100BT8009 - a Nectin-4-targeting Bicycle Toxin ConjugateBT8009-100BTRC 4017ABTX A51BusulfexbusulphanB-VaxxBVD-523BXCL701BYL719C188-9C3-targeted complement inhibitor APL-2CabometyxCACPCampothecin-11CamptoCamptosarcamptothecin-polymer conjugate IT-101CAPECaprelsaCarloxanCatequentinibCBT-101CCI-779CD4BCD80-Fc fusion protein ALPN-202CDA inhibitor E7727/decitabine combination agent ASTX727CDDPCDK inhibitor PF-06873600CDK inhibitor SCH 727965CDK2/5/9 inhibitor CYC065CDK4/6 Dual Inhibitor LY2835219CDK4/6 Inhibitor LEE011Cediranib maleateCerticancET FOXP3 antisense oligonucleotide AZD8701CH5126766Chimeric MoAb C225CiclofosfamidaCiclofosfamideCicloxalcis-DDPcis-platinumCisplatyl Citoplatino Citosin CK1alpha/CDK7/CDK9 inhibitor BTX-A51CKI27ClafenClapheneClevegenClofarexClolarClostridium novyi-NT sporesCM-24c-met/HGFR tyrosine kinase inhibitor PF-02341066CO-338Cometriqconditionally active biologic anti-CTLA4 antibody BA3071CORT125134Cotellic coxsackievirus A21CP monohydrateCP-675CP-675,206CP-675206CPI-444CPMCPX-006CRLX101CRM1 nuclear export inhibitor KPT-330CRX100CVA21CX-5461CYC065cyclin-dependent kinase inhibitor PF-06873600CycloblastinCycloblastineCYCLO-cellcyclodextrin-based polymer-camptothecin CRLX101CyclophosphamCyclophosphamid monohydrateCyclophosphamidumCyclophosphanCyclophosphanumCyclostinCyclostineCytophosphanCytophosphanecytotoxic lymphocyte maturation factor interleukin-12CytoxanDAB389 interleukin-2 immunotoxinDacotinDacplatDepaconDepakeneDFMODNA-PK inhibitor AZD7648DNA-PK inhibitor MSC2490484ADocetaxel Nanoparticle Formulated with Human AlbuminDoxildoxorubicin prodrug/prodrug-activating biomaterial SQ3370Dox-SLDRP-104DS-3032bDS-8201DS-8201aDual Innate Immune Activator SYNB1891dual PI3 kinase/mTOR inhibitor PKI-587E7080E7389E7438E7777Edodekin alfaEDO-S101EGEN-001EGFR mAb + TGFbetaRII Tumor-Targeted fusion mAbEloxatinEloxatineEMD 1036239enadenotucirev-expressing anti-CD40 agonistic monoclonal antibody NG-350enadenotucirev-expressing FAP/CD3 bispecific FAP-TAc NG-641endothelin B receptor blocker ENB 003EndoxanEndoxanaEnduxanEngineered red blood cells coexpressing 4-1BBL and IL-15TP RTX-240engineered toxin body-targeting HER2 MT-5111ENV-101EOS-850EP4 antagonist INV-1120epipodophyllotoxinEPZ6438ER-086526ER-203492-00ErbituxErivedgeERK 1/2 inhibitor ASTX029ERK inhibitor BVD-523ERK1/2 inhibitor ERAS-007ES002EunadesEvacetextended-release onapristonefam-trastuzumab deruxtecan-nxkiFaslodexFc-engineered anti-CD40 agonist antibody 2141-V11FemaraFGFR inhibitor TAS-120 Flt3 ligand/anti-CTLA-4 antibody/IL-12 engineered oncolytic Vaccinia virus RIVAL-01Fludara OralFMAb2Follicle Stimulating Hormone Receptor T CellsFortametFosfaseronFP-1305G protein-coupled estrogen receptor agonist LNS8801GDC-0068GDC-0077GDC-0084GDC-0449GDC-0973GDC-9545GemzarGenoxalGilotrifGL-ONC1GlucophageGlumetzaglutaminase inhibitor IPN60090GLV-1h68GM-CSF-encoding oncolytic herpes simplex virusGSK1120212GSK2110183GSK2118436GSK-2118436AGSK572016GW2016GX-I7hafnium oxide-containing nanoparticles NBTXR3Halavenhalichrondrin B analogHDAC inhibitor CRA-024781HDAC inhibitor SNDX-275HDC SN-38Hedgehog antagonist GDC-0449HER2 Monoclonal AntibodyHER2 tri-specific natural killer cell engager DF1001HerceptinhetIL-15histone methyl transferase EZH2 inhibitor E7438HKI-272HM30181AKHMPL-012HPN536 - a T cell engaging, mesothelin/CD3-specific TriTAChrS7-SN38 antibody drug conjugateHSP90-targeted SN-38 conjugate PEN-866human interleukin-7 mRNA-encoded BNT152HycamptamineHycamtinHydroxyl-DaunorubicinHyleukinHyperthermic Intraperitoneal ChemotherapyIACS-15509IbranceICI 182,780ICON-2ICP-192IL-12 mRNAIL-12sc, IL-15sushi, IFNa and GM-CSF mRNA-based immunotherapeutic agent SAR441000IL-15/IL-15 receptor alpha sushi+ domain fusion protein SO-C101IL15/IL15R alpha heterodimeric Fc-fusionsIL15/sIL-15R alphaIL-2R alpha-independent IL-2/IL-15 AgonistIMC-C103C, a T cell redirecting bi-specific biologicIMC-F106C, a T cell redirecting bi-specific biologicImfinziIMGN853immunocytokine NHS-IL12immunoglobulin G1 (human-mouse monoclonal rhuMab-VEGF gamma-chainINCMGA00012INK-1117InlytaInobrodibinositol-requiring enzyme 1 RNase inhibitor ORIN1001Interleukin-15 fusion protein BJ-001interleukin-15/interleukin-15 receptor alpha complex-Fc fusion protein XmAb24306interleukin-15/interleukin-15 receptor alpha sushi+ domain fusion protein SO-C101intermediate-affinity interleukin-2 receptor agonist ALKS 4230IPN60090iPSC-derived CD16/IL-15RF-expressing CD38-eliminated NK Cells FT538iPSC-derived NK cells FT500IrbinitinibIrradiationIT-101JNJ-61610588JS001JTP-74057JTX-1811JTX-4014KadcylaKeytrudaKisqaliKoselugoKPT-330KRAS G12C inhibitor MRTX849KRAS mutant-targeting AMG 510KRAS-MAPK signaling pathway inhibitor JAB-3312Lambrolizumablapatinib ditosylateLastetLederplatin LedoxinaLEE011LenvimaLGK974LGX818LibtayoLifirfeniblight-emitting oncolytic vaccinia virus GL-ONC1lipid nanoparticle encapsulating mRNA encoding human IL-12LipoDoxliposomal doxorubicinliposome-encapsulated irinotecan hydrochloride PEP02LM-302LOXO-101LOXO-292LY2853219LY2940680LY3214996LynparzaM3814M6620M7824M9241M9346A-sulfo-SPDB-DM4MCLA-128MDL 71782MDM2 antagonist RO5503781MDM2/MDMX inhibitor ALRN-6924MDM2-p53 inhibitor APG-115MDV3100MDV3800MDX 018MDX-010MDX-1106MEDI4736MEK Inhibitor GSK1120212MEK inhibitor MEK162MEK inhibitor PD0325901MEK162MekinistMektoviMEN 1309metal-organic framework (MOF) compound RiMO-301Metaplatin MethazolastoneMGA012MGD019microbiome GEN-001Milademetan tosylateMITO-CMitocinMitolemMitosolMitoxanMitozytrexMK1775MK-2140MK3475MK-3475MK4827MK-6018MK-7902ML-246MLN1117MM-121MM-398Modified Vaccinia Ankara (MVA) personalized vaccineModified Vaccinia Virus Ankara Vaccine Expressing p53 MOF compound RiMO-301monoclonal antibody 2C4Monoclonal Antibody B43.13monoclonal antibody TRK-950MOR210MPDL3280AMPS1 inhibitor CFI-402257MRTX849MS 275MSB0010718CMSB0011359CMSC1936369BMTIG7192Amultikinase inhibitor BAY 73-4506multi-kinase inhibitor TPX-0022multi-kinase inhibitor TT-00420multi-kinase inhibitor XL092MutamycinMVAp53myleranMyVACN-803nab-rapamycinnal-IRInanoliposomal irinotecanNanoparticle Albumin-Bound RapamycinNanoparticle Albumin-Bound Sirolimusnanoscale coordination polymer nanoparticles CPI-100natural killer cell stimulatory factor NM-IL-12NavelbineNavelbine ditartrateNCE401NCI-C04706NCP nanoparticles CPI-100NemvaleukinNeoplatin NeosarNIR178NKTR-214NLG207NLR family pyrin-domain-containing 3 agonist BMS-986299NOV120101NovoplatinumNovoTTF-100L(O)NSC 726189NT-I7NVBNVP-BKM120NY-ESO-1-loaded artificial adjuvant vector cell immunotherapeutic ASP0739OHPOMP-305B83OMP-313M32ONA-XRoncolytic adenoviral vector-expressing anti-CD40 agonistic antibodyoncolytic HSV-1-expressing IL-12 and anti-PD-1 antibody T3011oncolytic measles virus encoding thyroidal sodium iodide symporteroncolytic Newcastle disease virus MEDI9253oncolytic Vaccinia virus PF-07263689oncolytic virus ASP9801oncolytic virus RP1OnivydeONO-4538ONT-380OpdivoOvaRexp300 HAT/CREB binding protein inhibitor CCS1477p300/CBP bromodomain inhibitor CCS1477p53-HDM2 protein-protein interaction inhibitor APG-115Paclitaxel Albumin-Stabilized Nanoparticle FormulaPaclitaxel-loaded tumor penetrating microparticlespan FGFR Kinase Inhibitor BGJ398 pan-FGFR tyrosine kinase inhibitor JNJ-42756493pan-HER kinase inhibitor HM781-36BParaplatinPARP inhibitor BGB-290PBF-509PCI-24781PD-0325901PD0332991PD-0332991PD-1 selected TIL therapyPD1-Fc-OX40L ARC fusion proteinPD272PDR001PEG-PEI-cholesterol lipopolymer-encased IL-12 DNA plasmid vector GEN-1Pegtomarginasepegylated deoxycytidine analogue DFP-14927Pegylated Liposomal Doxorubicin Hydrochloridepegylated recombinant IL-2 variant THOR-707Pemetrexed disodiumPeposertibPerjetapertuzumab, trastuzumab, and hyaluronidase-zzxfPF 01367338PF-02341066PF-04554878PF-05212384PF-06463922PF-06801591PF3600PGE2 receptor antagonist INV-1120P-glycoprotein inhibitor HM30181AKPH20 hyaluronidase-expressing adenovirus VCN-01phIL-12-005/PPCPhosphate prodrug of alvocidibphosphoinositide 3-Kinase inhibitor BYL719PI3K alpha inhibitor MLN1117PI3K inhibitor BAY 80-6946PI3K inhibitor BYL719PI3K inhibitor GDC-0084PiqrayPKI-587PlacisPlaquenilPlatamine Platiblastin Platiblastin-S Platinex PlatinolPlatiranPlatistinPlatosinPLX4032Pol I inhibitor CX5461polyamine transport inhibitor AMXT-1501 dicapratePORCN inhibitor LGK974porcupine inhibitor WNT974 Praxelpressurized intraperitoneal aerosol chemotherapyPRMT5 inhibitor PRT811Procytoxprostaglandin E2 EP4 receptor inhibitor E7046PS-341PT100PTEF-b/CDK9 inhibitor VIP152PTPN11 inhibitor RMC-4630PXD101R788 sodiumRAD001RadiotherapyRaf Kinase Inhibitor LGX818Raf/MEK dual kinase inhibitor RO5126766RAIN-32RapamuneRapamycinRecentinrecombinant human IL-7-hybrid Fc NT-I7recombinant interleukin-12recombinant NDV expressing IL-12REGN2810RELARET kinase inhibitor LOXO-292RetevmoRG6114RG7388RG7440RG7446RG7666rhuMAb2C4ribocytokine IL-7 BNT152RiometRIVAL-01/TAK-605rizatriptan benzoateRLI 15RLY-1971RMI-71782RNA Pol I inhibitor CX5461Ro 24-7472RO5126766RO5185426RO5503781RO7092284RozlytrekRP-3500RubracaRXDX-101SAR256212SAR442720SCH 727965SCH 900475selective estrogen receptor downregulator GDC-9545selective inhibitor of nuclear export KPT-330SendoxanSGN TGTSHP2 inhibitor RMC-4630SHP2 inhibitor TNO155SIRPaFcSKI-606Smac Mimetic TL32711SMO8502SNDX-275SO-C101SotorasibSPEAR T-cell ADP-A2M4CD8SprycelSQL70/SQP33SRF373SRF813STA-12-8666StavzorSTING agonist GSK3745417StivargaSTP705SulfatinibSunitinib malatesuperagonist interleukin-15:interleukin-15 receptor alphaSu/Fc fusion complex N-803SutentSyk kinase inhibitor R935788SyklofosfamidTAA-specific cytotoxic T lymphocytesTAB-001TafinlarTAK-117talabostat mesylateTalazoparib Tosylate TalzennaTarcevaTAS-120TasignaTaxolTaxol KonzentratTaxotereTazverikTbio-6517TC-210 T cellsTC-210 TruC-T cellsT-DM1T-DxdTecentriqTemodalTemodarTH 3424Thorium-227 Labeled Antibody-chelator Conjugate BAY2701439threonine tyrosine kinase inhibitor CFI-402257TIC10TicilimumabTJ004309TJ011133TJ033721TJ107TJ210001TJC4TJD5TJ-L14BTL32711TMT212toll-like receptor 7 agonist DSP-0509TOPOToposarToriselTPX-0005trastuzumab-DM1trastuzumab-MCC-DM1trastuzumab-MCC-DM1 antibody-drug conjugatetrastuzumab-MCC-DM1 immunoconjugateTRC102T-regulatory cell-depleting antibody RO7296682triptolide analogueTrk inhibitor LOXO-101TrkA inhibitor VMD-928TrkA/B/C/ROS1/ALK tyrosine kinase inhibitor RXDX-101TrodelvyTRPV6 calcium channel inhibitor SOR-C13TSR-042TTK inhibitor CFI-402257T-VECTXLTykerbUpRiVal-boro-ProValproate VaniqaVE-822VebreltinibVelcadeVePesidVerzenioVinorelbine ditartrateVinorelbine tartrateViraceptVitrakviVLS-101VNBVotrientVS-6063VX-803VX-970WEE1 inhibitor AZD1775WR-138720WT1-loaded artificial adjuvant vector cell immunotherapeutic ASP7517XalkoriXelodaXL184XL518XmAb20717XmAb717XmAb841XMT-1536XpovioXtandiYervoyZactimaZD6474ZD9238ZejulaZelborafZEN003694ZortressZytoxanαGal immunotherapy Tumor Genomic Alteration: selectABL1AKT1AKT2AKT2 AMPAKT3ALKALK AMPARID1AATMATRATRXAXLBAP1BARD1Bcr-ablBLMBRAFBRAF V600BRAF V600EBRIP1CCND1 AMPCCND2 AMPCCND3 AMPCCNE1 AMPCD274 (PD-L1)CDK12CDK4 AMPCDK6 AMPCDKN2ACHEK1CHEK2cKITCREBBPCSF1RCTNNB1DDR2EGFR EGFR AMPEIF1AXEMSY AMPEP300EPHA2ERBB2 (aka HER2)ERBB2 AMPERBB3 (aka HER3)ERBB3 AMPERBB4 (aka HER4)ERCC1ERCC2FAM175AFANCA FANCA AMPFANCC FANCC AMPFANCD2 FANCD2 AMPFANCE FANCE AMPFANCFFANCGFANCLFBXW7FGFFGFR1 FGFR1 AMPFGFR2 FGFR2 AMPFGFR3 FGFR3 AMPFGFR4FGFR4 AMPFLT3FYNGNA11GNAQHRASIDH1IDH2KDRKDR AMPKEAP1KITKIT AMPKRAS KRAS AMPLCKLKB1LYNMAP2K1MAP2K2MDM4MDM2MET MET AMPMLH1MLL2MRE11AMSH2MSH6mTORMTAPMYC AMPMYCN AMPNBNNF1NF2NRASNFE2L2NRG1NTRK1NTRK2NTRK3PALB2PARP1PARP2PDGFRPDGFRAPDGFRA AMPPDGFRBPIK3CA PIK3CA AMPPIK3CB AMPPIK3CB PIK3R1PMS2POLD1POLEPOLQPRKDCPPP2R2APTCH1PTENRAD50RAD51RAD51BRAD51CRAD51DRAD54LRB1RAF1RETRNF43ROS1RSPOSETD2SLX4SF3B1SMARCB1SMARCA4SMOSRCSRSF2TIPARP AMPTORC1TORC2TP53TRKTSC1TSC2VEGFRU2AF1WRNXRCCYES1ZRSR2 Return only trials with results Include all Phase 1 trials (i.e., dose-finding as well as expansion) Criteria Arm: All All12345 Matching Trials Save Trials For more detailed information please click on the clinical trial number and you will be taken to the clinicaltrials.gov website. For a key to the icons and text used in the Results column, please click here. To learn more about our trial annotation process, results assignments, and the criteria used to highlight drugs with promising results, please click here. Clinical Trial Phase Eligible Participant Official Title Location Drugs in Trial Results NCT05092373IAdvanced solid tumors involving the abdomen or thorax with ≥1% PD-L1 expression on tumor-infiltrating immune cells (inc expansion)Phase I Study of Tumor Treating Fields (TTF) in Combination With Cabozantinib, or With Atezolizumab and Nab-Paclitaxel in Patients With Advanced Solid Tumors Involving the Abdomen or ThoraxTXView Drugs View Results Drug(s) in Trial Other Drug Names Main Known Action Drug Status TTfieldsNovoTTF-100L(O)Microtubule destabilizer/mitotic inhibitorClinical TrialsAtezolizumabTecentriq, Anti-PD-L1 Monoclonal Antibody MPDL3280A, MPDL3280A, RG7446Blocks PD-L1 inhibition of T cellsApproved in Other Cancersnab-PaclitaxelPaclitaxel Albumin-Stabilized Nanoparticle Formula, Abraxane, ABI-007Microtubule stabilizer/mitotic inhibitorNCCN Guidelines for Ovarian Cancer If you have any questions or would like help with your search, please call us at: 858-657-0282 or email us at patientsupport@clearityfoundation.org. × If you have any questions or would like help with your search, please call us at: 858-657-0282 or email us at patientsupport@clearityfoundation.org. × Results for ovarian cancer patients in the same or similar trial Promising results for ovarian cancer patients in the same or similar trial Results for a small number of ovarian cancer patients in the same or similar trial Promising results for a small number of ovarian cancer patients in the same or similar trial Results for patients with other cancer types in the same trial View Results Results for ovarian cancer patients in a different trial with same or similar drugs View Results Promising results for ovarian cancer patients in a different trial with same or similar drugs View Results Results for patients with other cancer types